Maria Giulia Mosconi

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation

Maurizio Paciaroni, Giancarlo Agnelli, Nicola Falocci et al. · Stroke · 2015 · 271 citations · Full text

Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOACs) Study

Maurizio Paciaroni, Giancarlo Agnelli, Nicola Falocci et al. · Journal of the American Heart Association · 2017 · 132 citations · Full text

Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes

Maurizio Paciaroni, Fabio Bandini, Giancarlo Agnelli et al. · Journal of the American Heart Association · 2018 · 94 citations · Full text

Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention

Maurizio Paciaroni, Giancarlo Agnelli, Valeria Caso et al. · Stroke · 2019 · 91 citations · Full text